FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA granted supplemental approval for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cobicistat (cobicistat)
• Emtricitabine (Emtricitabine)
• Tenofovir alafenamide (tenofovir alafenamide)
• elvitegravir (elvitegravir)

Snippet

SUPPL AP for GENVOYA (ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)